Follow-up
ADVERSE EVENTS
After treatment, patients will already be followed at the outpatient clinic according to standard of care of EBRT and ADT. The first visits will take place at three and 6 months (see Table STwo additional follow-up procedures will take place for this phase I study: first, during the third and 6 months visits patients are also asked to fill out EORTC questionnaires (QLQ-C30 and QLQ-PR25) and second, during the first 2 months of follow-up (recovery period) patients will be contacted twice to check for (serious) adverse events (see Table SAfter 6 months of follow-up the study will end.